Industry Experts

Yan Gu is an experienced CMC expert in the gene and cell therapy space. She has experience in CMC drug development for allogeneic cell therapy, AAV, and lipid nanoparticle (LNP) non-viral gene therapy products at Vertex Pharmaceuticals, Takeda and Sanofi. Prior to her cell and gene therapy endeavors, she also worked on multiple late-phase monoclonal antibody programs at BMS. She holds a PhD in Chemistry from Iowa State University and completed her postdoctoral training at Harvard University.